IA
LFCR icon

IndexIQ Advisors’s Lifecore Biomedical LFCR Stock Holding History

IndexIQ Advisors’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-66,052
Closed -$747K – 1101
2019
Q4 		$747K Sell
66,052
-20,965
-24% -$223K 0.03% 378
2019
Q3 		$946K Sell
87,017
-16,301
-16% -$177K 0.03% 381
2019
Q2 		$968K Buy
103,318
+45,144
+78% +$456K 0.03% 418
2019
Q1 		$714K Buy
+58,174
New +$710K 0.02% 457

Other funds holding LFCR

WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
ICOM
Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return
WC
Walthausen & Co Malta, New York $120M AUM 2.66% 1-Year Est. Return

IndexIQ Advisors's LFCR Position: Q1 2020 in Review

IndexIQ Advisors sold out of Lifecore Biomedical (LFCR) in Q1 2020, closing a stake of 66,052 shares — an estimated $747K sold.

IndexIQ Advisors first reported a position in LFCR in Q1 2019 and held it in 4 quarters. The position peaked at $968K in Q2 2019. 88 funds tracked by Wall St. Rank hold LFCR as of Q1 2020.

  • IndexIQ Advisors reported no remaining Lifecore Biomedical position as of Q1 2020 after selling out during the quarter.
  • IndexIQ Advisors sold 66,052 Lifecore Biomedical shares in Q1 2020, an estimated $747K.
  • IndexIQ Advisors first reported a position in Lifecore Biomedical in Q1 2019 and held it in 4 quarters.
  • IndexIQ Advisors's Lifecore Biomedical position peaked at $968K in Q2 2019.
  • 88 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q1 2020.

Based on IndexIQ Advisors's 13F filing for Q1 2020, filed 8 May 2020.